This study from The Lancet Neurology speaks to the focus on using MSCs to treat patients with ongoing inflammation in conditions like multiple sclerosis. Early clinical trials have demonstrated the safety of MSC treatments, paving the way for larger studies to assess their effectiveness in improving clinical outcomes.
Menu
